David Lopez Email & Phone Number

New Jersey, United States

Raritan, New Jersey, US

Raritan, New Jersey, US

• Built successful professional relationships with thought leaders in the rare disease space at academic and clinical practices throughout New York to provide scientific expertise, clinical trial support, and the.
• Served as the MSL representative on the ERA brand team to aid in the development of MSL-specific initiatives and strategies, which align with the medical brand plans
• Served on the Field Community Committee connecting field teams to other Janssen colleagues enhancing the sense of community
• Served as a reviewer for ERA-focused MSL decks on the MSL publications team to refine and enhance data dissemination to HCPs
• Helped identify opportunities to improve the IT experience by optimizing the use of technology for the MSL team as the IT lead
• Facilitated updates and problem resolution between the RESTORE clinical trial team, MSLs, and their respective sites

Raritan, New Jersey, US

London, New York, Los Angeles, Manchester, GB

• Medical Affairs
• Developed medical and commercial content for global pharmaceutical clients with a focus on hematology, oncology, and cardiology for conferences, journals, internal training, and regulatory affairs
• Experienced in phases of drug development and clinical trials within the context of medical writing
• Facilitated Latin American advisory boards with key opinion leaders, translated medical presentations, wrote meeting reports, and liaised between all stakeholders
• Provided strategic support to pharmaceutical clients through scientific platform development

New York, NY, US

• Project Title: Endothelial-Specific Overexpression of MAPK Signaling Mimics Hematopoietic AgingBackground: Age-related changes in the hematopoietic system include a compromised immune system and an increase in the.
• Researched, designed and executed scientific experiments in the fields of regenerative medicine, immunology, and oncology to determine how the overexpression of MAPK signaling in BMECs affects the progression of acute.
• Developed mouse models and in vitro vascular platforms to examine leukemia progression and enhance regenerative blood production following ablative conditioning
• Isolated cultures of BMECs and niche cells using a unique protocol developed in the Butler lab
• Designed and implemented a lentiviral cloning strategy with a colleague to reduce cell line development costs and investigate MAPK mechanisms
• Thoroughly surveyed scientific literature for all data pertaining to a novel systemic protein to validate the proposed experimental design that is currently producing positive data for publication

Gainesville, Florida, US

• Project Title: Defining the Immune System’s Role in Vertebrate RegenerationBackground: Immune cells are involved in wound healing responses throughout the body, and may even determine the balance between scarring and.
• Pioneered the development of a salamander animal model in the Scott Lab to investigate blood in regenerative healing, earning a plenary paper award and the cover of a world-renowned hematology and medical journal, Blood
• Performed thousands of surgeries while altering variables, troubleshooting and clearly documenting results to systematically understand the model and publish a detailed methods paper
• Created new tools and standard operating procedures specific for the salamander animal model with limited resources due to the novelty of the project, lowering overall future development costs
• Overcame challenges such as graft-versus-host disease in myeloablative and non-conditioned allogeneic hematopoietic cell transplantation models through embryo manipulation, microsurgeries and donor cell harvest during.
• Established a FACS enrichment technique for major blood lineages through light scatter characteristics due to a lack of commercially available antibodies

London, ON, CA

Synthesized a series of monomers and then chemically linked them to make biomimetic polymers for tissue engineering scaffolds.- Characterized polymers using NMR, TGA, DSC, IR, and GPC- Ran biodegradation and cytocompatibility studies on the polymers- Work resulted in a publication